Sign in

CIK 0001534120

  • Non-accelerated filer
  • Smaller reporting company

Avalo Therapeutics, Inc.

Sign in to watch
Ticker
AVTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
450705648
Phone
+1 410-522-8707
Business address
1500 LIBERTY RIDGE DRIVE, SUITE 321, WAYNE, PA, 19087
Former names
Cerecor Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$395,474
in 3 filings, $395K under 10b5-1 plans

Net −$395,474. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-10-01 COLA MICHAEL F Chief Executive Officer Grant or award · Stock Option (Right to Buy) +78,116 78,116
2021-07-01 COLA MICHAEL F Chief Executive Officer Grant or award · Stock Option (Right to Buy) +51,740 51,740
2021-04-01 COLA MICHAEL F Chief Executive Officer Grant or award · Stock Option (Right to Buy) +70,881 70,881
2021-01-26 COLA MICHAEL F Chief Executive Officer Grant or award · Stock Option (Right to Buy) +850,000 850,000
2021-01-04 COLA MICHAEL F Chief Executive Officer Grant or award · Stock Option (Right to Buy) +64,798 64,798
2020-10-01 COLA MICHAEL F Chief Executive Officer Grant or award · Stock Option (Right to Buy) +76,674 76,674
2020-07-01 COLA MICHAEL F Chief Executive Officer Grant or award · Stock Option (Right to Buy) +64,683 64,683
2020-06-18 COLA MICHAEL F Chief Executive Officer Grant or award · Stock Option (Right to Buy) +84,322 84,322
2020-06-09 COLA MICHAEL F Chief Executive Officer Purchase +100,000 $2.50 $250K 175,746
2020-02-03 COLA MICHAEL F Chief Executive Officer Grant or award +75,746 75,746
2020-02-03 COLA MICHAEL F Chief Executive Officer Grant or award · Stock Option (Right to Buy) +1,200,000 1,200,000

Page 1 of 1 · 11 trades